Astragaloside IV Alleviates Cerebral Ischemia‐Reperfusion Injury through NLRP3 Inflammasome‐Mediated Pyroptosis Inhibition via Activating Nrf2
Cited by 124
Related Papers
NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway
|Journal of Inflammation|2020|37